CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 123 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q3 2023. The put-call ratio across all filers is 1.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $389 | -28.0% | 17,818 | +4.8% | 0.00% | -25.0% |
| Q2 2023 | $540 | +14.9% | 17,000 | -11.7% | 0.00% | +33.3% |
| Q1 2023 | $470 | -20.7% | 19,263 | +2.4% | 0.00% | -25.0% |
| Q4 2022 | $593 | -99.9% | 18,808 | -3.2% | 0.00% | 0.0% |
| Q3 2022 | $549,000 | +123.2% | 19,432 | +109.1% | 0.00% | +100.0% |
| Q2 2022 | $246,000 | -23.4% | 9,292 | +1.5% | 0.00% | 0.0% |
| Q1 2022 | $321,000 | +18.5% | 9,159 | +9.5% | 0.00% | +100.0% |
| Q4 2021 | $271,000 | +34.2% | 8,364 | +22.4% | 0.00% | 0.0% |
| Q3 2021 | $202,000 | – | 6,834 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAIN CAPITAL INVESTORS LLC | 60,632,356 | $1,965,701,000 | 23.51% |
| Affinity Asset Advisors, LLC | 225,000 | $7,295,000 | 2.65% |
| Perceptive Advisors | 10,173,454 | $329,822,000 | 2.54% |
| Artal Group S.A. | 1,500,000 | $48,630,000 | 1.32% |
| Rock Springs Capital Management LP | 1,648,435 | $53,442,000 | 1.24% |
| RTW INVESTMENTS, LP | 666,666 | $21,613,000 | 0.32% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 8,900 | $289,000 | 0.28% |
| EAM Investors, LLC | 39,907 | $1,294,000 | 0.21% |
| FEDERATED HERMES, INC. | 3,113,333 | $100,934,000 | 0.19% |
| Alkeon Capital Management | 1,909,035 | $61,891,000 | 0.12% |